Pharmacotherapy to Support PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Pharmacotherapy to Support PCI== | ||
===[[Antiplatelet Therapy to Support PCI]]=== | |||
===[[Antithrombin Therapy to Support PCI]]=== | |||
===[[Statin therapy to support PCI]]=== | |||
==References== | ==References== | ||
Line 13: | Line 13: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Needs overview]] |
Revision as of 18:38, 4 January 2013
Percutaneous coronary intervention Microchapters |
PCI Complications |
---|
PCI in Specific Patients |
PCI in Specific Lesion Types |
Pharmacotherapy to Support PCI On the Web |
American Roentgen Ray Society Images of Pharmacotherapy to Support PCI |
Directions to Hospitals Treating Percutaneous coronary intervention |
Risk calculators and risk factors for Pharmacotherapy to Support PCI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]